Association of calcineurin with mitochondrial proteins

Proteins: Structure, Function and Genetics

Volumn 64, Issue 1, 2006, Pages 28-33

  Tokheim, Abigail M ^a   Martin, Bruce L ^a,b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Calcineurin; Mass spectrometry; Mouse heart; Partner proteins; Proteomics

Indexed keywords

ACONITATE HYDRATASE; ANTIBODY; CALCINEURIN; ISOCITRATE DEHYDROGENASE; MALATE DEHYDROGENASE; MANGANESE SUPEROXIDE DISMUTASE; MITOCHONDRIAL ENZYME; MITOCHONDRIAL PROTEIN; TRYPSIN;

AMINO ACID SEQUENCE; ARTICLE; COMPLEX FORMATION; DATA BASE; EXTRACTION; IMMUNOPRECIPITATION; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PROTEIN INTERACTION; SILVER STAINING; TANDEM MASS SPECTROMETRY; WESTERN BLOTTING;

ACONITATE HYDRATASE; ANIMALS; CALCINEURIN; MALATE DEHYDROGENASE; MICE; MITOCHONDRIA, HEART; SUPEROXIDE DISMUTASE;

EID: 33744788332     PISSN: 08873585     EISSN: 10970134     Source Type: Journal    
DOI: 10.1002/prot.20996     Document Type: Article

References (37)

1. Griffith JP, Kim JL, Kim EE, et al. X-ray structure of calcineurin inhibited by the immunophilin-immunosuppressant FKBP12-FK506 complex. Cell 1995;82:507-522.
2. Kissinger CR, Perge HE, Knighton DR, et al. Crystal structures of human calcineurin and the human FKBP12-FK506-calcineurin complex. Nature 1995;378:641-644.
3. Ladner CJ, Czech J, Maurice J, Lorens SA, Lee JM. Reduction of calcineurin enzymatic activity in Alzheimer's disease: correlation with neuropathologic changes. J Neuropathol Exp Neurol 1996;55:924-931.
4. Gong C-X, Singh T, Grundke-Iqbal I, Iqbal K. Alzheimer's disease abnormally phosphorylated tau is dephosphorylation by protein phosphatase-2B (calcineurin). J Neurohem 1994;62:803-806.
5. Wang J-Z, Gong C-X, Zaidi T, Grundke-Iqbal I, Iqbal K. Dephosphorylation of Alzheimer paired helical filaments by protein phosphatase-2A and -2B. J Biol Chem 1995;270:4854-4860.
6. Thomas GD, O'Rourke B, Sikkink R, Rusnak F, Marban E, Victor RG. Differential modulation of cortical synaptic activity by calcineurin (phosphatase 2B) versus phosphatases 1 and 2A. Brain Res 1997;749:101-108.
7. Desdouits F, Buxbaum JD, Desdouits-Magnen J, Nairn AC, Greengard P. Amyloid alpha peptide formation in cell-free preparations. Regulation by protein kinase C, calmodulin, and calcineurin. J Biol Chem 1996;271:24670-24674.
8. Nichols RA, Suplick GR, Brown JM. Calcineurin-mediated protein dephosphorylation in brain nerve terminals regulates the release of glutamate. J Biol Chem 1994;269:23817-23823.
9. Winder DG, Mansuy IM, Osman M, Moallem TM, Kandel ER. Genetic and pharmacological evidence for a novel, intermediate phase of long-term potentiation suppressed by calcineurin. Cell 1998;92:25-37.
10. Liu J, Farmer JD Jr, Lane WS, Friedman J, Weissman I, Schreiber SL. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 1991;66:807-815.
11. Swanson SK-H, Born T, Zydowsky LD, et al. Cyclosporin-mediated inhibition of bovine calcineurin by cyclophilins A and B. Prob Natl Acad Sci USA 1992;89:3741-3745.
12. McCaffrey PG, Perrino BA, Soderling TR, Rao A. NF-ATp, a T lymphocyte DNA-binding protein that is a target for calcineurin and immunosuppressive drugs. J Biol Chem 1993;268:3747-3752.
13. Lu YF, Tomizawa K, Moriwaki A, et al. Calcineurin inhibitors, FK506 and cyclosporin A, suppress the NMDA receptor-mediated potentials and LTP, but not depotentiation in the rat hippocampus. Brain Res 1996;729:142-146.
14. Martina M, Mozrzymas JW, Boddeke HW, Cherubini E. The calcineurin inhibitor cyclosporin A-cyclophilin A complex reduces desensitization of GABAA-mediated responses in acutely dissociated rat hippocampal neurons. Neurosci Lett 1996;215:95-98.
15. Molkentin JD, Lu JR, Antos CL, et al. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 1998;93:215-228.
16. Sussman MA, Lim HW, Gude N, et al. Prevention of cardiac hypertrophy in mice by calcineurin inhibition. Science 1998;281:1690-1693.
17. Chin ER, Olson EN, Richardson JA, et al. A calcineurin-dependent transcriptional pathway controls skeletal muscle fiber type. Genes Dev 1998;12:2499-2509.
18. Zhang W, Kowal RC, Rusnak F, Sikkink RA, Olson EN, Victor RG. Failure of calcineurin inhibitors to prevent pressure-overload left ventricular hypertrophy in rats. Circ Res 1999;84:722-728.
19. Ding B, Price RL, Borg TK, Weinberg EO, Halloran PF, Lorell BH. Pressure overload induces severe hypertrophy in mice treated with cyclosporine, an inhibitor of calcineurin. Circ Res 1999;84:729-734.
20. Lim HW, De Windt LJ, Mante J, et al. Reversal of cardiac hypertrophy in transgenic disease models by calcineurin inhibition. J Mol Cell Cardiol 2000;32:697-709.
21. Shevchenko A, Wilm M, Vorm O, Mann M. Mass spectrometric sequencing of proteins from silver-stained polyacrylamide gels. Anal Chem 1996;68:850-858.
22. Ferri A, Gabbianelli R, Casciati A, Paolucci E, Rotilio G, Carri MT. Calcineurin activity is regulated both by redox compounds and by familial amyotrophic lateral sclerosis-superoxide dismutase. J Neurochem 2000;75:606-613.
23. Ferri A, Gabbianelli R, Casciati A, Celsi F, Rotilio G, Carri MT. Oxidative inactivation of calcineurin by Cu,Zn superoxide dismutase G93A, a mutant typical of familial amyotrophic lateral sclerosis. J Neurochem 2001;79:531-538.
24. Volkel H, Scholz M, Link J, et al. Superoxide dismutase mutations of familial amyotrophic lateral sclerosis and the oxidative inactivation of calcineurin. FEBS Lett 2001;503:201-205.
25. Wang X, Culotta VC, Klee CB. Superoxide dismutase protects calcineurin from inactivation. Nature 1996;383:434-437.
26. Tsujimoto Y. Cell death regulation by the Bcl-2 protein family in the mitochondria. J Cell Physiol 2003;195:158-167.
27. Srivastava RK, Sasaki CY, Hardwick JM, Longo DL. Bcl-2-mediated drug resistance: inhibition of apoptosis by blocking nuclear factor of activated T lymphocytes (NFAT)-induced Fas ligand transcription. J Exp Med 1999;190:254-265.
28. Clipstone NA, Crabtree GR. Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation. Nature 1992;357:695-697.
29. Furuke K, Shiraishi M, Mostowski HS, Bloom ET. Fas ligand induction in human NK cells is regulated by redox through a calcineurin-nuclear factors of activated T cell-dependent pathway. J Immunol 1999;162:1988-1993.
30. Broekemeier KM, Dempsey ME, Pfeiffer DR. Cyclosporin A is a potent inhibitor of the inner permeability transition in liver mitochondria. J Biol Chem 1989;264:7826-7830.
31. Hansson MJ, Persson T, Friberg H, et al. Powerful cyclosporin inhibition of calcium-induced permeability transition in brain mitochondria. Brain Res 2003;960:99-111.
32. Skulachev VP. Why are mitochondria involved in apoptosis? Permeability transition pores and apoptosis as selective mechanisms to eliminate superoxide-producing mitochondria and cell. FEBS Lett 1996;397:7-10.
33. Sayen MR, Gustafsson AB, Sussman MA, Molkentin JD, Gottlieb RA. Calcineurin transgenic mice have mitochondrial dysfunction and elevated superoxide production. Am J Physiol Cell Physiol 2003;284:C562-C570.
34. Huang TT, Carlson EJ, Kozy HM, et al. Genetic modification of prenatal lethality and dilated cardiomyopathy in Mn superoxide dismutase mutant mice. Free Radic Biol Med 2001;31:1101-1110.
35. Melov S, Coskun P, Patel M, et al. Mitochondrial disease in superoxide dismutase 2 mutant mice. Proc Natl Acad Sci USA 1999;96:846-851.
36. Yan L-J, Levine RL, Sohal RS. Oxidative damage during aging targets mitochondrial aconitase. Proc Natl Acad Sci USA 1997;94:11168-11172.
37. Tanaka T, Morita H, Koide H, Kawamura K, Takatsu T. Biochemical and morphological study of cardiac hypertrophy. Effects of thyroxine on enzyme activities in the rat myocardium. Basic Res Cardiol 1985;80:165-174.